Document is current
Any future updates will be listed below
-
Authors
Oliveira, Victor Davi R. S. https://orcid.org/0009-0009-2930-8088
Reis, Ana Paula M. G.
Brenol, Claiton V.
Pereira, Ivânio A.
Bonfiglioli, Karina R.
Pereira, Letícia R.
Bértolo, Manoel B.
de Fátima L. C. Sauma, Maria
Guimarães, Maria Fernanda B. R.
Louzada-Júnior, Paulo
Giorgi, Rina D. N.
Radominski, Sebastião C.
Mota, Licia Maria H.
Albuquerque, Cleandro P.
Castelar-Pinheiro, Geraldo R.
-
Funding
Funding for this research was provided by:
Sociedade Brasileira de Reumatologia
- License Information
-
More Information
Article History
Received: 26 September 2024
Accepted: 18 November 2024
First Online: 19 December 2024
Declarations
:
: The authors Victor Davi Rosa e Silva de Oliveira, Letícia Rocha Pereira, Manoel Barros Bértolo, Maria de Fátima Lobato da Cunha Sauma, Paulo Louzada Júnior, Cleandro Pires de Albuquerque, and Geraldo da Rocha Castelar-Pinheiro declare that they have no conflicts of interest. Ana Paula Monteiro Gomides Reis: Has received speaking fees and support for educational activities from AbbVie, Pfizer, and Janssen. Has participated in advisory boards for AbbVie and Pfizer. Claiton Viegas Brenol: Has participated in clinical and/or experimental studies related to this work and sponsored by AbbVie, BMS, Janssen, Pfizer, and Roche; has received personal or institutional support from AbbVie, BMS, Janssen, Pfizer, and Roche; has delivered speeches at events related to this work and sponsored by AbbVie, Janssen, Pfizer, and Roche. Ivânio Alves Pereira: Has received consulting fees, speaking fees, and support for international congresses from Roche, Pfizer, UCB Pharma, Eli-Lilly, AbbVie, and Janssen. Following completion of this work, Ivânio Alves Pereira has changed affiliation to Universidade do Sul de Santa Catarina. Karina Rossi Bonfiglioli: Has received speaking fees and support for educational activities from AbbVie, UCB, Janssen, Pfizer. Maria Fernanda Brandão de Resende Guimarães: Has received speaking fees and support for international congresses from Amgen, AbbVie, UCB, Lilly, and Janssen. Rina Dalva Neubarth Giorgi: Has participated in advisory boards and received speaking fees and support for international congresses from Eli Lilly, Biocon, Novartis, Janssen, AbbVie, and Fresenius Kabi. Sebastião Cezar Radominski: Has received speaking fees from AbbVie, Janssen, Novartis, and Pfizer; has participated in clinical studies sponsored by AbbVie and Novartis. Lícia Maria Henrique da Mota: Has received personal or institutional support from AbbVie, Janssen, Pfizer, and Roche; has delivered speeches at events related to this work and sponsored by AbbVie, Boehringer Ingelheim, GSK, Janssen, Libbs, Lilly, Novartis, Pfizer, Roche, Sandoz, and UCB.
: The study was approved by the National Commission of Ethics in Research (CONEP—Comissão Nacional de Ética em Pesquisa, Brazilian Ministry of Health) and by institutional review boards of each participating center (protocol number CAAE 45781015.8.1001.5259). All patients provided written informed consent prior to inclusion in the study. The study was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.
